Capitalmind
Capitalmind
Premium

Portfolio: Strides Merger Pushes it Up, Time for an Options Play

On the portfolio we have some quick news. Strides Arcolab: Buys Shasun, Gets a 50% Return on Stelis investment Strides will merge with Shasun Pharma, in an ...